Economics of prevention: The public health research agenda

Journal of Public Health Management and Practice

Volumn 10, Issue 5, 2004, Pages 467-471

  Chattopadhyay, Sajal K ^a   Carande Kulis, Vilma G ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

cost benefit; cost effectiveness; demand; economic evaluation; financing; market imperfections; regulatory; supply

Indexed keywords

ARTICLE; ECONOMICS; HEALTH SERVICE; HUMAN; POLICY; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; RESEARCH;

HEALTH SERVICES NEEDS AND DEMAND; HUMANS; PREVENTIVE HEALTH SERVICES; PUBLIC HEALTH; PUBLIC POLICY; RESEARCH;

EID: 16544370937     PISSN: 10784659     EISSN: 15505022     Source Type: Journal    
DOI: 10.1097/00124784-200409000-00015     Document Type: Article

References (29)

1. Centers for Medicare and Medicaid Services (CMS). Table 2: National Health Expenditure Amounts and Average Percent Change by Type of Expenditure: Selected Calendar Years 1980-2012. Available at: www.cms.hhs.gov/statistics/nhe/projections-2002/t2.asp. Accessed January 5, 2004.
2. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). The Power of Prevention: Reducing Health and Economic Burden of Chronic Disease. Atlanta: CDC; 2003.
3. US Department of Health and Human Services. Prevention Makes Common "Cents." September 2003. Available at: http://aspe.hhs.gov/health/prevention/. Accessed December 12, 2003.
4. Centers for Disease Control and Prevention. Effectiveness in disease and injury prevention: estimated national spending on prevention—United States, 1988. Morbidity and Mortality Weekly Report. 1992;41(29):529-531.
5. Mc Ginnis JM, Willams-Russo P, Knickman JR. The case for more active policy attention to health promotion. Health Affairs. 2002;21(2):78-93.
6. Agency for healthcare Research and Quality. United States Preventive Services Task Force. Available at: www.ahcpr.gov/clinic/uspstfix.htm. Accessed December 12, 2003.
7. Centers for Disease and Prevention, Community Guide Branch. Guide to Community Preventive Services. Available at: www.thecommunityguide.org/. Accessed December 12, 2003.
8. Grossman M. On the concept of health capital and the demand for health. Journal of Political Economy. 1972;80(2):223-255.
9. Wu S. Sickness and preventive medical behavior. Journal of Health Economics. 2003;22(4):675-689.
10. Kenkel DS. The demand for preventive medical care. Applied Economics. 1994;26:313-325.
11. Grossman M, Rand E. Consumer incentives for health services in chronic illness. In: Mushkin SJ, ed. Consumer Incentives for Health Care. New York: Milbank Memorial Fund; 1974, 114-151.
12. Cropper ML. Health, Investment in health and occupational choice. Journal of Political Economy. 1977; 85: 1273-1294.
13. Phelps CE. Illness prevention and medical insurance. Journal of Human Resources. 1978;13:183-207.
14. Nordquist G, Wu S. The joint demand for health insurance and preventive medicine. In: Rosett R, ed. The Role of Health Insurance in the Health Services Sector. New York: National Bureau of Economic Research; 1976.
15. Philipson T. Economic epidemiology and infectious diseases. In: Culyer AJ, Newhouse JP, eds. Handbook of Health Economics. Volume 1B. The Netherlands: Elsevier Science BV; 2000, 1762-1799.
16. Ahituv A, Hotz VJ, Philipson T. The responsiveness of the demand for condoms to the local prevalence of AIDS. Journal of Human Resources. 1996;31(4):869-897.
17. Dowd BE. Financing preventive care in HMOs: a theoretical analysis. Inquiry. 1982;19:68-78.
18. Lewis JD, Asch DA. Barriers to office-based screening sigmoidoscopy: does reimbursement cover costs? Ann Intern Med. 1999;130:525-530.
19. Kenkel DS. Prevention. In: Culyer AJ, Newhouse JP, eds. Handbook of Health Economics. Volume 1B. The Netherlands: Elsevier Science BV; 2000, 1676-1720.
20. Zweifel P, Breyer F. Health Economics. New York: Oxford University Press; 1997.
21. Dranove D. Is there Underinvestment in R and D about prevention? Journal of Health Economics. 1998;17(1):117-127.
22. Dow WH, Holmes J, Philipson T. Sala-i-Martin X. Disease complementarities and the evaluation of public health interventions [National Bureau of Economic Research Working Paper No. 5216]. Available at:http://papers.nber.org/papers/W5216. Accessed January 12, 2004.
23. Boozer MA, Philipson TJ. The impact of public testing for Human Immunodeficiency Virus. The Journal of Human Resources. 2000;35(3):419-446.
24. Parente ST, Salkever DS, DaVanzo J. The role of consumer knowledge of insurance benefits in the demand for preventive health care among the elderly [National Bureau of Economic Research Working Paper No. 9912]. Available at:http://papers.nber.org/papers/W9912. Accessed January 12, 2004.
25. Chou S-Y, Grossman M, Saffer H. An economic analysis of adult obesity: results from the behavioral risk factor surveillance system [National Bureau of Economic Research Working Paper No. 9247]. Available at:http://papers.nber.org/papers/W9247. Accessed January 12, 2004.
26. Hamilton J. The demand for cigarettes: advertising, the health scare, and the cigarette advertising ban. The Review of Economics and Statistics. 1972;54(4);401-411.
27. Evans WN, Farrelly Mc. The compensating behavior of smokers: taxes, tar and nicotine. The RAND Journal of Economics. 1998;29(3): 578-595.
28. Gruber J, Mullainathan S. Do cigarette taxes make smokers happier? [National Bureau of Economic Research Working Paper No. 8872]. Available at: http://papers.nber.org/papers/W8872. Accessed January 12, 2004.
29. Mansley EC, Dunet DO, May DS, Chattopadhyay SK, Mc Kenna MT. Variation in average costs among federally sponsored state-organized cancer detection programs: economies of scale? Medical Decision Making. 2002;22(suppl):S67-S79.